Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission

@article{Versluis2015PredictionON,
  title={Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remission},
  author={J Pieter Versluis and Myriam Labopin and Dietger Niederwieser and G{\'e}rard Soci{\'e} and Richard F Schlenk and N{\"o}el Milpied and Sabine van der Veer and Didier Blaise and V Luis Fernando Rocha and Jan Jacob Cornelissen and Mohamad Mohty},
  journal={Leukemia},
  year={2015},
  volume={29},
  pages={51-57}
}
Non-relapse mortality (NRM) after allogeneic hematopoietic stem cell transplantation (alloHSCT) can be predicted by the hematopoietic cell transplantation comorbidity index (HCT-CI) and the European Group for Blood and Marrow Transplantation (EBMT) score, which are composed of different parameters. We set out to integrate the parameters of both scores in patients with acute myeloid leukemia (AML) in first complete remission (CR1) receiving reduced intensity conditioning (RIC) alloHSCT. All… CONTINUE READING
BETA

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

European Group for Blood and Marrow Transplantation Risk Score Predicts the Outcome of Patients with Acute Leukemia Receiving Single Umbilical Cord Blood Transplantation.

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2017

Prognostic Scoring Systems in Allogeneic Hematopoietic Stem Cell Transplantation: Where Do We Stand?

  • Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 38 REFERENCES

Hema - topoietic SCT in Europe : data and trends in 2011

ME Charlson, P Pompei, KL Ales, CR MacKenzie
  • Bone Marrow Transplant
  • 2013